Published in Med Biol on January 01, 1984
Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture. Antimicrob Agents Chemother (1987) 1.25
Activity of the cytomegalovirus genome in the presence of PPi analogs. J Virol (1985) 0.87
Antiherpesvirus activity and mechanism of action of indolo-(2,3-b)quinoxaline and analogs. Antimicrob Agents Chemother (1988) 0.84
Influence of cells and virus multiplicity on the inhibition of herpesviruses with acycloguanosine. Intervirology (1980) 1.50
Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture. Antimicrob Agents Chemother (1987) 1.25
A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds. J Virol Methods (1983) 1.19
Intracellular pools of thymidine reduce the antiviral action of acyclovir. Intervirology (1983) 1.16
Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet. Antimicrob Agents Chemother (1989) 1.13
Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate. Antimicrob Agents Chemother (1988) 1.10
Computer-based virus sensitivity assay and neutralization method. Applications for herpesviruses. J Virol Methods (1983) 1.02
Nucleoside pools of acyclovir-treated herpes simplex type 1 infected cells. Antiviral Res (1985) 0.96
Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds. Antimicrob Agents Chemother (1990) 0.95
Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity. J Clin Virol (2001) 0.95
Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds. J Antimicrob Chemother (1985) 0.95
Combinations of antiviral and anti-inflammatory preparations for the topical treatment of herpes simplex virus assessed using a murine zosteriform infection model. Antivir Chem Chemother (1998) 0.94
Comparative methods for detection of thymidine kinase-deficient herpes simplex virus type 1 strains. Antimicrob Agents Chemother (1986) 0.92
Effects of ribonucleotide reductase inhibition on pyrimidine deoxynucleotide metabolism in acyclovir-treated cells infected with herpes simplex virus type 1. Antimicrob Agents Chemother (1988) 0.92
Herpes simplex virus type 1 infection and glucocorticoid treatment regulate viral yield, glucocorticoid receptor and NF-kappaB levels. J Endocrinol (2002) 0.89
Influence of cell culture conditions on the inhibition of herpes simplex virus type 1 replication by acyclovir. Intervirology (1982) 0.87
Effect of acyclovir and presence of cellular and viral thymidine kinase activity in herpes simplex virus infected cells. Brief report. Arch Virol (1982) 0.86
Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis. Antimicrob Agents Chemother (2002) 0.86
Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1. Antimicrob Agents Chemother (1989) 0.84
Herpes simplex virus zosteriform lesions with adoptive transfer of immune cells: a murine model which mimics human recurrent disease. Antiviral Res (1998) 0.82
Possible tumour markers in patients with oesophagus cancer. Scand J Gastroenterol (1979) 0.82
Synergistic inhibition of human immunodeficiency virus isolates (including 3'-azido-3'-deoxythymidine-resistant isolates) by foscarnet in combination with 2',3'-dideoxyinosine or 2',3'-dideoxycytidine. Antimicrob Agents Chemother (1996) 0.81
Physiological and morphological characteristics of world class fencers. Int J Sports Med (1990) 0.80
Comparison of sample preparation methods for the high-performance liquid chromatographic analysis of cell culture extracts for triphosphate ribonucleosides and deoxyribonucleosides. Anal Biochem (1987) 0.78
Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract. Urol Res (1985) 0.78
Deoxythymidine pools in animal and human skin with reference to antiviral drugs. Arch Dermatol Res (1985) 0.77
Deoxythymidine pools of human skin and guinea pig organs. FEBS Lett (1985) 0.77
Antiviral activity of low-dose alovudine in antiretroviral-experienced patients: results from a 4-week randomized, double-blind, placebo-controlled dose-ranging trial. HIV Med (2007) 0.75
Limitations of cytomegalovirus testing. Antimicrob Agents Chemother (1999) 0.75
Intermittent rG-CSF treatment in cyclic neutropenia. Eur J Haematol (1992) 0.75
[New aspects in the diagnosis and treatment of herpes infections]. Tandlakartidningen (1986) 0.75
Pseudouridine and uridine in normal kidney and kidney cancer tissues. Urol Res (1985) 0.75
New tools for the herpes virologist. Int J Technol Assess Health Care (1988) 0.75
Synergistic combinations and peptides in the inhibition of human immunodeficiency virus. Adv Enzyme Regul (1991) 0.75
Assay of intracellular thymidylate synthetase activity and inhibition by 5-fluoro-2'-deoxyuridine in lymphocytes. J Biochem Biophys Methods (1992) 0.75